blood sugar control – Globalstar International https://export.globalstarco.com Making Health Accessible. Fri, 02 Jan 2026 02:31:15 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 https://export.globalstarco.com/wp-content/uploads/2025/07/cropped-Site-Icon-32x32.png blood sugar control – Globalstar International https://export.globalstarco.com 32 32 Semaglutide Injection https://export.globalstarco.com/product/semaglutide-injection-exporter/ https://export.globalstarco.com/product/semaglutide-injection-exporter/#respond Fri, 08 Aug 2025 07:30:49 +0000 https://wordpress-1556924-6036175.cloudwaysapps.com/product/semaglutide-injection/ Overview

Semaglutide Injection is a once-weekly GLP-1 receptor agonist used to improve glycaemic control in adults with type 2 diabetes and to support weight management when indicated. It works by enhancing insulin release, reducing glucagon secretion, and slowing gastric emptying.

Key Benefits

  • Improves blood glucose control in type 2 diabetes
  • Supports clinically meaningful weight reduction when combined with diet and exercise
  • Convenient once-weekly dosing via a prefilled pen

Composition

Active ingredient: Semaglutide.

How It Works

Acts as a GLP-1 receptor agonist to increase insulin secretion in a glucose-dependent manner, decrease glucagon, and slow gastric emptying, thereby reducing appetite.

Usage Directions

  • Inject subcutaneously once weekly as prescribed by a healthcare professional.
  • Rotate injection sites and follow the prescribing information for dose titration.

Possible Side Effects

  • Nausea, vomiting, diarrhea
  • Decreased appetite
  • Occasional dizziness

Precautions

  • Not indicated for type 1 diabetes or diabetic ketoacidosis.
  • Use under medical supervision; monitor for gastrointestinal effects and kidney function in susceptible patients.

Storage Instructions

  • Store refrigerated at 2°C–8°C until first use; after first use follow pen storage instructions.
  • Do not freeze; protect from direct heat and sunlight.

Manufacturer

Novo Nordisk

]]>
https://export.globalstarco.com/product/semaglutide-injection-exporter/feed/ 0
Tirzepatide (2.5mg) Tablet https://export.globalstarco.com/product/tirzepatide-2-5mg-tablet-exporter-from-india/ https://export.globalstarco.com/product/tirzepatide-2-5mg-tablet-exporter-from-india/#respond Sun, 27 Jul 2025 05:18:26 +0000 https://wordpress-1556924-6036175.cloudwaysapps.com/product/tirzepatide-2-5mg-tablet/ Overview: Mounjaro 2.5mg Solution for Injection is prescribed to manage blood sugar levels in adults with type 2 diabetes. It is used alongside diet and exercise to improve glycemic control. Key Benefits: – Helps in significant reduction of blood sugar – Supports weight management in diabetic patients – Once-weekly injectable formulation Composition: Each pre-filled pen contains: Tirzepatide 2.5mg How It Works: Tirzepatide is a dual GIP and GLP-1 receptor agonist. It enhances insulin secretion, lowers glucagon levels, and slows gastric emptying, leading to better glucose regulation. Usage Directions: – Administer subcutaneously once weekly, on the same day each week – Can be injected in the abdomen, thigh, or upper arm – Follow your physician’s dosage instructions carefully Possible Side Effects: – Nausea and vomiting – Decreased appetite – Diarrhea or constipation – Injection site reactions – Risk of hypoglycemia (especially with other antidiabetics) Precautions: – Not for use in type 1 diabetes or diabetic ketoacidosis – Inform doctor if pregnant or breastfeeding – Regular blood glucose monitoring is essential Storage Instructions: – Store between 2°C and 8°C in a refrigerator – Do not freeze – Keep out of reach of children Manufacturer: Eli Lilly and Company India Pvt Ltd Disclaimer: This information is for educational use only and should not replace professional medical advice. Please consult your doctor for guidance regarding your health.

]]>
https://export.globalstarco.com/product/tirzepatide-2-5mg-tablet-exporter-from-india/feed/ 0
Insulin Isophane (70%) + Human insulin (30%) Injection https://export.globalstarco.com/product/insulin-isophane-70-human-insulin-30-injection-exporter-from-india/ https://export.globalstarco.com/product/insulin-isophane-70-human-insulin-30-injection-exporter-from-india/#respond Sun, 27 Jul 2025 05:17:36 +0000 https://wordpress-1556924-6036175.cloudwaysapps.com/product/insulin-isophane-70-human-insulin-30-injection/ Overview: Huminsulin 30/70 Suspension for Injection 100IU/ml is a combination insulin formulation used for the effective management of diabetes mellitus. It helps control blood glucose levels in people with diabetes and reduces complications associated with high blood sugar. Key Benefits: – Helps regulate blood sugar in diabetic patients – Combines intermediate-acting and short-acting insulin for better glycemic control – Reduces risk of diabetic complications Composition: Each ml contains Insulin Isophane (70%) + Human insulin (30%) How It Works: Huminsulin 30/70 contains a combination of isophane insulin (intermediate-acting) and regular insulin (short-acting). It mimics the natural insulin action, helping cells absorb glucose and reducing blood glucose levels effectively. Usage Instructions: – Administer subcutaneously as directed by your doctor – Do not shake the vial; roll it gently between hands – Use a sterile syringe and needle each time – Rotate injection sites to prevent lipodystrophy Possible Side Effects: – Hypoglycemia (low blood sugar) – Weight gain – Local site reactions such as redness or swelling – Itching or rash Precautions: – Monitor blood sugar levels regularly – Inform your doctor if pregnant, breastfeeding, or on other medications – Avoid skipping or delaying meals Storage Instructions: – Store in a refrigerator (2 – 8°C) – Do not freeze – Keep away from direct light and out of reach of children Manufacturer: Eli Lilly and Company India Pvt Ltd Disclaimer: The information provided is for educational purposes only. Please consult your physician before using any medication.

]]>
https://export.globalstarco.com/product/insulin-isophane-70-human-insulin-30-injection-exporter-from-india/feed/ 0